UC rejects tobacco money ban

The University of California finally made the decision to allow researchers to accept funding from tobacco companies last month, the Sacramento Bee linkurl:reported;http://www.sacbee.com/101/story/391011.html . As I linkurl:wrote;http://www.the-scientist.com/news/display/44525/ in January, the issue had been brewing since 2004, when several UC campuses voted not to accept funding from tobacco companies, falling in line with several other prominent research institutions. The university has accep

Written byAndrea Gawrylewski
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The University of California finally made the decision to allow researchers to accept funding from tobacco companies last month, the Sacramento Bee linkurl:reported;http://www.sacbee.com/101/story/391011.html . As I linkurl:wrote;http://www.the-scientist.com/news/display/44525/ in January, the issue had been brewing since 2004, when several UC campuses voted not to accept funding from tobacco companies, falling in line with several other prominent research institutions. The university has accepted over $16 million from Philip Morris and other tobacco companies since 2005, a fraction of the gifts and pledges made to the university, which in 2006 totaled about $1.3 billion. Since this time last year, the issue has been passed back and forth between the Board of Regents and the UC faculty several times, and the decision was delayed twice since it came before the Board in January of this year. Many UC faculty I spoke to in January were critical of president Robert Dynes, and felt that he was fighting tooth and nail to reject the ban. As Dynes is scheduled to step down from the presidency effective next June, it will be interesting to see if this issue stays on the Regents' agenda, or goes the way of the beleaguered president. Stanton Glantz, professor of medicine at the University of California at San Francisco and long-time critic of tobacco funding for research, responded to me with only a one-lined Email when I asked for his reaction to the ban rejection: "It's not over yet."
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA